Moreover, combination of LSD1 inhibitors and the ferroptosis inducer RSL resulted in an enhanced inhibition of tumor growth in a xenograft model of human lung cancer cells compared to either treatment alone. The gene discussed is KDM1A; the disease is lung carcinoma.